nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—sarcoma—melanoma	0.341	1	CtDrD
Epirubicin—AURKA—melanoma	0.321	1	CbGaD
Epirubicin—ABCC1—Vemurafenib—melanoma	0.0798	0.498	CbGbCtD
Epirubicin—ABCC1—Dactinomycin—melanoma	0.053	0.331	CbGbCtD
Epirubicin—ABCC1—Docetaxel—melanoma	0.0274	0.171	CbGbCtD
Epirubicin—DHCR7—hair follicle—melanoma	0.00166	0.111	CbGeAlD
Epirubicin—CHD1—retina—melanoma	0.00122	0.0813	CbGeAlD
Epirubicin—CHD1—mammalian vulva—melanoma	0.000977	0.0651	CbGeAlD
Epirubicin—TOP2A—Paclitaxel—Docetaxel—melanoma	0.000932	1	CbGdCrCtD
Epirubicin—DHCR7—retina—melanoma	0.000823	0.0548	CbGeAlD
Epirubicin—AURKA—mammalian vulva—melanoma	0.000788	0.0525	CbGeAlD
Epirubicin—Doxorubicin—AURKA—melanoma	0.000778	0.383	CrCbGaD
Epirubicin—YWHAG—eye—melanoma	0.000762	0.0507	CbGeAlD
Epirubicin—YWHAG—retina—melanoma	0.000755	0.0503	CbGeAlD
Epirubicin—DHCR7—skin of body—melanoma	0.000723	0.0481	CbGeAlD
Epirubicin—CHD1—head—melanoma	0.000699	0.0466	CbGeAlD
Epirubicin—DHCR7—mammalian vulva—melanoma	0.000659	0.0439	CbGeAlD
Epirubicin—ABCC1—hair follicle—melanoma	0.000651	0.0434	CbGeAlD
Epirubicin—YWHAG—mammalian vulva—melanoma	0.000605	0.0403	CbGeAlD
Epirubicin—AURKA—head—melanoma	0.000564	0.0375	CbGeAlD
Epirubicin—CHD1—lymph node—melanoma	0.00049	0.0326	CbGeAlD
Epirubicin—DHCR7—head—melanoma	0.000471	0.0314	CbGeAlD
Epirubicin—PLA2G4A—mammalian vulva—melanoma	0.000451	0.03	CbGeAlD
Epirubicin—YWHAG—head—melanoma	0.000433	0.0288	CbGeAlD
Epirubicin—TOP2A—mammalian vulva—melanoma	0.000428	0.0285	CbGeAlD
Epirubicin—AURKA—lymph node—melanoma	0.000395	0.0263	CbGeAlD
Epirubicin—Daunorubicin—CYP1B1—melanoma	0.000382	0.188	CrCbGaD
Epirubicin—Doxorubicin—NOS2—melanoma	0.000364	0.179	CrCbGaD
Epirubicin—DHCR7—lymph node—melanoma	0.00033	0.022	CbGeAlD
Epirubicin—Doxorubicin—CYP1B1—melanoma	0.00031	0.152	CrCbGaD
Epirubicin—YWHAG—lymph node—melanoma	0.000303	0.0202	CbGeAlD
Epirubicin—ABCC1—mammalian vulva—melanoma	0.000258	0.0172	CbGeAlD
Epirubicin—PLA2G4A—lymph node—melanoma	0.000226	0.015	CbGeAlD
Epirubicin—TOP2A—lymph node—melanoma	0.000215	0.0143	CbGeAlD
Epirubicin—ABCC1—lymph node—melanoma	0.000129	0.00861	CbGeAlD
Epirubicin—Daunorubicin—ABCB1—melanoma	0.00011	0.0539	CrCbGaD
Epirubicin—Doxorubicin—ABCB1—melanoma	8.89e-05	0.0437	CrCbGaD
Epirubicin—Alopecia—Temozolomide—melanoma	6.35e-05	0.00068	CcSEcCtD
Epirubicin—Dry skin—Docetaxel—melanoma	6.34e-05	0.000678	CcSEcCtD
Epirubicin—Myalgia—Bleomycin—melanoma	6.32e-05	0.000677	CcSEcCtD
Epirubicin—Chest pain—Bleomycin—melanoma	6.32e-05	0.000677	CcSEcCtD
Epirubicin—Orthostatic hypotension—Docetaxel—melanoma	6.31e-05	0.000676	CcSEcCtD
Epirubicin—Abdominal pain upper—Docetaxel—melanoma	6.31e-05	0.000676	CcSEcCtD
Epirubicin—Rash—Vemurafenib—melanoma	6.3e-05	0.000675	CcSEcCtD
Epirubicin—Mental disorder—Temozolomide—melanoma	6.3e-05	0.000675	CcSEcCtD
Epirubicin—Dermatitis—Vemurafenib—melanoma	6.3e-05	0.000674	CcSEcCtD
Epirubicin—Back pain—Carmustine—melanoma	6.27e-05	0.000671	CcSEcCtD
Epirubicin—Headache—Vemurafenib—melanoma	6.26e-05	0.000671	CcSEcCtD
Epirubicin—Malnutrition—Temozolomide—melanoma	6.26e-05	0.00067	CcSEcCtD
Epirubicin—Erythema—Temozolomide—melanoma	6.26e-05	0.00067	CcSEcCtD
Epirubicin—Breast disorder—Docetaxel—melanoma	6.25e-05	0.000669	CcSEcCtD
Epirubicin—Discomfort—Bleomycin—melanoma	6.24e-05	0.000668	CcSEcCtD
Epirubicin—Malaise—Dactinomycin—melanoma	6.24e-05	0.000668	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Docetaxel—melanoma	6.23e-05	0.000667	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Docetaxel—melanoma	6.23e-05	0.000667	CcSEcCtD
Epirubicin—Leukopenia—Dactinomycin—melanoma	6.2e-05	0.000663	CcSEcCtD
Epirubicin—Nasopharyngitis—Docetaxel—melanoma	6.18e-05	0.000662	CcSEcCtD
Epirubicin—Dysgeusia—Temozolomide—melanoma	6.13e-05	0.000656	CcSEcCtD
Epirubicin—Confusional state—Bleomycin—melanoma	6.11e-05	0.000654	CcSEcCtD
Epirubicin—Vision blurred—Carmustine—melanoma	6.11e-05	0.000654	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Docetaxel—melanoma	6.1e-05	0.000653	CcSEcCtD
Epirubicin—Anaphylactic shock—Bleomycin—melanoma	6.06e-05	0.000649	CcSEcCtD
Epirubicin—Oedema—Bleomycin—melanoma	6.06e-05	0.000649	CcSEcCtD
Epirubicin—Back pain—Temozolomide—melanoma	6.06e-05	0.000648	CcSEcCtD
Epirubicin—Infection—Bleomycin—melanoma	6.02e-05	0.000644	CcSEcCtD
Epirubicin—Anaemia—Carmustine—melanoma	5.99e-05	0.000641	CcSEcCtD
Epirubicin—Dysphagia—Docetaxel—melanoma	5.97e-05	0.00064	CcSEcCtD
Epirubicin—Agitation—Carmustine—melanoma	5.95e-05	0.000637	CcSEcCtD
Epirubicin—Nausea—Vemurafenib—melanoma	5.94e-05	0.000636	CcSEcCtD
Epirubicin—Thrombocytopenia—Bleomycin—melanoma	5.93e-05	0.000635	CcSEcCtD
Epirubicin—Vision blurred—Temozolomide—melanoma	5.9e-05	0.000632	CcSEcCtD
Epirubicin—Myalgia—Dactinomycin—melanoma	5.89e-05	0.000631	CcSEcCtD
Epirubicin—Discomfort—Dactinomycin—melanoma	5.82e-05	0.000623	CcSEcCtD
Epirubicin—Angina pectoris—Docetaxel—melanoma	5.82e-05	0.000623	CcSEcCtD
Epirubicin—Ill-defined disorder—Temozolomide—melanoma	5.81e-05	0.000622	CcSEcCtD
Epirubicin—Leukopenia—Carmustine—melanoma	5.8e-05	0.000621	CcSEcCtD
Epirubicin—Anaemia—Temozolomide—melanoma	5.79e-05	0.00062	CcSEcCtD
Epirubicin—Anorexia—Bleomycin—melanoma	5.77e-05	0.000618	CcSEcCtD
Epirubicin—Agitation—Temozolomide—melanoma	5.75e-05	0.000616	CcSEcCtD
Epirubicin—Pancytopenia—Docetaxel—melanoma	5.67e-05	0.000608	CcSEcCtD
Epirubicin—Hypotension—Bleomycin—melanoma	5.66e-05	0.000606	CcSEcCtD
Epirubicin—Oedema—Dactinomycin—melanoma	5.65e-05	0.000605	CcSEcCtD
Epirubicin—Malaise—Temozolomide—melanoma	5.65e-05	0.000604	CcSEcCtD
Epirubicin—Vertigo—Temozolomide—melanoma	5.62e-05	0.000602	CcSEcCtD
Epirubicin—Convulsion—Carmustine—melanoma	5.61e-05	0.000601	CcSEcCtD
Epirubicin—Infection—Dactinomycin—melanoma	5.61e-05	0.000601	CcSEcCtD
Epirubicin—Leukopenia—Temozolomide—melanoma	5.6e-05	0.0006	CcSEcCtD
Epirubicin—Hypertension—Carmustine—melanoma	5.59e-05	0.000599	CcSEcCtD
Epirubicin—Neutropenia—Docetaxel—melanoma	5.59e-05	0.000598	CcSEcCtD
Epirubicin—Palpitations—Temozolomide—melanoma	5.53e-05	0.000592	CcSEcCtD
Epirubicin—Thrombocytopenia—Dactinomycin—melanoma	5.53e-05	0.000592	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Bleomycin—melanoma	5.52e-05	0.000591	CcSEcCtD
Epirubicin—Chest pain—Carmustine—melanoma	5.52e-05	0.000591	CcSEcCtD
Epirubicin—Myalgia—Carmustine—melanoma	5.52e-05	0.000591	CcSEcCtD
Epirubicin—Anxiety—Carmustine—melanoma	5.5e-05	0.000588	CcSEcCtD
Epirubicin—Cough—Temozolomide—melanoma	5.46e-05	0.000585	CcSEcCtD
Epirubicin—Paraesthesia—Bleomycin—melanoma	5.44e-05	0.000582	CcSEcCtD
Epirubicin—Weight increased—Docetaxel—melanoma	5.44e-05	0.000582	CcSEcCtD
Epirubicin—Convulsion—Temozolomide—melanoma	5.42e-05	0.000581	CcSEcCtD
Epirubicin—Weight decreased—Docetaxel—melanoma	5.41e-05	0.000579	CcSEcCtD
Epirubicin—Hypertension—Temozolomide—melanoma	5.4e-05	0.000579	CcSEcCtD
Epirubicin—Dyspnoea—Bleomycin—melanoma	5.4e-05	0.000578	CcSEcCtD
Epirubicin—Anorexia—Dactinomycin—melanoma	5.38e-05	0.000577	CcSEcCtD
Epirubicin—Pneumonia—Docetaxel—melanoma	5.36e-05	0.000574	CcSEcCtD
Epirubicin—Confusional state—Carmustine—melanoma	5.33e-05	0.000571	CcSEcCtD
Epirubicin—Myalgia—Temozolomide—melanoma	5.33e-05	0.000571	CcSEcCtD
Epirubicin—Arthralgia—Temozolomide—melanoma	5.33e-05	0.000571	CcSEcCtD
Epirubicin—Infestation—Docetaxel—melanoma	5.33e-05	0.00057	CcSEcCtD
Epirubicin—Infestation NOS—Docetaxel—melanoma	5.33e-05	0.00057	CcSEcCtD
Epirubicin—Anxiety—Temozolomide—melanoma	5.31e-05	0.000569	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	5.29e-05	0.000567	CcSEcCtD
Epirubicin—Oedema—Carmustine—melanoma	5.29e-05	0.000566	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Docetaxel—melanoma	5.28e-05	0.000566	CcSEcCtD
Epirubicin—Discomfort—Temozolomide—melanoma	5.27e-05	0.000564	CcSEcCtD
Epirubicin—Decreased appetite—Bleomycin—melanoma	5.27e-05	0.000564	CcSEcCtD
Epirubicin—Infection—Carmustine—melanoma	5.25e-05	0.000562	CcSEcCtD
Epirubicin—Renal failure—Docetaxel—melanoma	5.24e-05	0.000561	CcSEcCtD
Epirubicin—Neuropathy peripheral—Docetaxel—melanoma	5.22e-05	0.000559	CcSEcCtD
Epirubicin—Dry mouth—Temozolomide—melanoma	5.21e-05	0.000558	CcSEcCtD
Epirubicin—Jaundice—Docetaxel—melanoma	5.19e-05	0.000556	CcSEcCtD
Epirubicin—Stomatitis—Docetaxel—melanoma	5.19e-05	0.000556	CcSEcCtD
Epirubicin—Pain—Bleomycin—melanoma	5.18e-05	0.000555	CcSEcCtD
Epirubicin—Conjunctivitis—Docetaxel—melanoma	5.18e-05	0.000554	CcSEcCtD
Epirubicin—Thrombocytopenia—Carmustine—melanoma	5.18e-05	0.000554	CcSEcCtD
Epirubicin—Tachycardia—Carmustine—melanoma	5.16e-05	0.000552	CcSEcCtD
Epirubicin—Confusional state—Temozolomide—melanoma	5.15e-05	0.000552	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dactinomycin—melanoma	5.15e-05	0.000551	CcSEcCtD
Epirubicin—Oedema—Temozolomide—melanoma	5.11e-05	0.000547	CcSEcCtD
Epirubicin—Anaphylactic shock—Temozolomide—melanoma	5.11e-05	0.000547	CcSEcCtD
Epirubicin—Infection—Temozolomide—melanoma	5.08e-05	0.000543	CcSEcCtD
Epirubicin—Anorexia—Carmustine—melanoma	5.04e-05	0.00054	CcSEcCtD
Epirubicin—Hepatobiliary disease—Docetaxel—melanoma	5.04e-05	0.000539	CcSEcCtD
Epirubicin—Epistaxis—Docetaxel—melanoma	5.02e-05	0.000538	CcSEcCtD
Epirubicin—Nervous system disorder—Temozolomide—melanoma	5.01e-05	0.000536	CcSEcCtD
Epirubicin—Thrombocytopenia—Temozolomide—melanoma	5e-05	0.000536	CcSEcCtD
Epirubicin—Feeling abnormal—Bleomycin—melanoma	4.99e-05	0.000534	CcSEcCtD
Epirubicin—Agranulocytosis—Docetaxel—melanoma	4.97e-05	0.000532	CcSEcCtD
Epirubicin—Skin disorder—Temozolomide—melanoma	4.96e-05	0.000531	CcSEcCtD
Epirubicin—Hypotension—Carmustine—melanoma	4.94e-05	0.000529	CcSEcCtD
Epirubicin—Hyperhidrosis—Temozolomide—melanoma	4.94e-05	0.000529	CcSEcCtD
Epirubicin—Decreased appetite—Dactinomycin—melanoma	4.91e-05	0.000526	CcSEcCtD
Epirubicin—Fatigue—Dactinomycin—melanoma	4.87e-05	0.000521	CcSEcCtD
Epirubicin—Anorexia—Temozolomide—melanoma	4.87e-05	0.000521	CcSEcCtD
Epirubicin—Pain—Dactinomycin—melanoma	4.83e-05	0.000517	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Carmustine—melanoma	4.82e-05	0.000516	CcSEcCtD
Epirubicin—Urticaria—Bleomycin—melanoma	4.81e-05	0.000515	CcSEcCtD
Epirubicin—Haemoglobin—Docetaxel—melanoma	4.81e-05	0.000515	CcSEcCtD
Epirubicin—Rhinitis—Docetaxel—melanoma	4.79e-05	0.000513	CcSEcCtD
Epirubicin—Body temperature increased—Bleomycin—melanoma	4.79e-05	0.000513	CcSEcCtD
Epirubicin—Haemorrhage—Docetaxel—melanoma	4.78e-05	0.000512	CcSEcCtD
Epirubicin—Hepatitis—Docetaxel—melanoma	4.78e-05	0.000512	CcSEcCtD
Epirubicin—Insomnia—Carmustine—melanoma	4.78e-05	0.000512	CcSEcCtD
Epirubicin—Hypoaesthesia—Docetaxel—melanoma	4.76e-05	0.000509	CcSEcCtD
Epirubicin—Paraesthesia—Carmustine—melanoma	4.75e-05	0.000508	CcSEcCtD
Epirubicin—Pharyngitis—Docetaxel—melanoma	4.75e-05	0.000508	CcSEcCtD
Epirubicin—Urinary tract disorder—Docetaxel—melanoma	4.72e-05	0.000506	CcSEcCtD
Epirubicin—Dyspnoea—Carmustine—melanoma	4.71e-05	0.000505	CcSEcCtD
Epirubicin—Oedema peripheral—Docetaxel—melanoma	4.71e-05	0.000504	CcSEcCtD
Epirubicin—Somnolence—Carmustine—melanoma	4.7e-05	0.000503	CcSEcCtD
Epirubicin—Connective tissue disorder—Docetaxel—melanoma	4.7e-05	0.000503	CcSEcCtD
Epirubicin—Urethral disorder—Docetaxel—melanoma	4.69e-05	0.000502	CcSEcCtD
Epirubicin—Feeling abnormal—Dactinomycin—melanoma	4.66e-05	0.000498	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Temozolomide—melanoma	4.65e-05	0.000498	CcSEcCtD
Epirubicin—Insomnia—Temozolomide—melanoma	4.62e-05	0.000495	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dactinomycin—melanoma	4.62e-05	0.000495	CcSEcCtD
Epirubicin—Visual impairment—Docetaxel—melanoma	4.61e-05	0.000493	CcSEcCtD
Epirubicin—Decreased appetite—Carmustine—melanoma	4.6e-05	0.000492	CcSEcCtD
Epirubicin—Paraesthesia—Temozolomide—melanoma	4.59e-05	0.000491	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Carmustine—melanoma	4.56e-05	0.000489	CcSEcCtD
Epirubicin—Dyspnoea—Temozolomide—melanoma	4.56e-05	0.000488	CcSEcCtD
Epirubicin—Somnolence—Temozolomide—melanoma	4.54e-05	0.000486	CcSEcCtD
Epirubicin—Erythema multiforme—Docetaxel—melanoma	4.52e-05	0.000484	CcSEcCtD
Epirubicin—Pain—Carmustine—melanoma	4.52e-05	0.000484	CcSEcCtD
Epirubicin—Constipation—Carmustine—melanoma	4.52e-05	0.000484	CcSEcCtD
Epirubicin—Dyspepsia—Temozolomide—melanoma	4.5e-05	0.000482	CcSEcCtD
Epirubicin—Eye disorder—Docetaxel—melanoma	4.47e-05	0.000479	CcSEcCtD
Epirubicin—Abdominal pain—Dactinomycin—melanoma	4.47e-05	0.000478	CcSEcCtD
Epirubicin—Body temperature increased—Dactinomycin—melanoma	4.47e-05	0.000478	CcSEcCtD
Epirubicin—Hypersensitivity—Bleomycin—melanoma	4.46e-05	0.000478	CcSEcCtD
Epirubicin—Decreased appetite—Temozolomide—melanoma	4.44e-05	0.000476	CcSEcCtD
Epirubicin—Flushing—Docetaxel—melanoma	4.44e-05	0.000475	CcSEcCtD
Epirubicin—Cardiac disorder—Docetaxel—melanoma	4.44e-05	0.000475	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Temozolomide—melanoma	4.41e-05	0.000472	CcSEcCtD
Epirubicin—Fatigue—Temozolomide—melanoma	4.4e-05	0.000472	CcSEcCtD
Epirubicin—Pain—Temozolomide—melanoma	4.37e-05	0.000468	CcSEcCtD
Epirubicin—Constipation—Temozolomide—melanoma	4.37e-05	0.000468	CcSEcCtD
Epirubicin—Feeling abnormal—Carmustine—melanoma	4.36e-05	0.000466	CcSEcCtD
Epirubicin—Asthenia—Bleomycin—melanoma	4.35e-05	0.000465	CcSEcCtD
Epirubicin—Angiopathy—Docetaxel—melanoma	4.34e-05	0.000465	CcSEcCtD
Epirubicin—Gastrointestinal pain—Carmustine—melanoma	4.32e-05	0.000463	CcSEcCtD
Epirubicin—Immune system disorder—Docetaxel—melanoma	4.32e-05	0.000463	CcSEcCtD
Epirubicin—Mediastinal disorder—Docetaxel—melanoma	4.31e-05	0.000461	CcSEcCtD
Epirubicin—Chills—Docetaxel—melanoma	4.29e-05	0.000459	CcSEcCtD
Epirubicin—Pruritus—Bleomycin—melanoma	4.29e-05	0.000459	CcSEcCtD
Epirubicin—Arrhythmia—Docetaxel—melanoma	4.27e-05	0.000457	CcSEcCtD
Epirubicin—Alopecia—Docetaxel—melanoma	4.23e-05	0.000452	CcSEcCtD
Epirubicin—Feeling abnormal—Temozolomide—melanoma	4.21e-05	0.000451	CcSEcCtD
Epirubicin—Mental disorder—Docetaxel—melanoma	4.19e-05	0.000449	CcSEcCtD
Epirubicin—Body temperature increased—Carmustine—melanoma	4.18e-05	0.000448	CcSEcCtD
Epirubicin—Abdominal pain—Carmustine—melanoma	4.18e-05	0.000448	CcSEcCtD
Epirubicin—Gastrointestinal pain—Temozolomide—melanoma	4.18e-05	0.000447	CcSEcCtD
Epirubicin—Malnutrition—Docetaxel—melanoma	4.16e-05	0.000446	CcSEcCtD
Epirubicin—Erythema—Docetaxel—melanoma	4.16e-05	0.000446	CcSEcCtD
Epirubicin—Hypersensitivity—Dactinomycin—melanoma	4.16e-05	0.000446	CcSEcCtD
Epirubicin—Dysgeusia—Docetaxel—melanoma	4.08e-05	0.000437	CcSEcCtD
Epirubicin—Urticaria—Temozolomide—melanoma	4.06e-05	0.000435	CcSEcCtD
Epirubicin—Asthenia—Dactinomycin—melanoma	4.05e-05	0.000434	CcSEcCtD
Epirubicin—Abdominal pain—Temozolomide—melanoma	4.04e-05	0.000432	CcSEcCtD
Epirubicin—Body temperature increased—Temozolomide—melanoma	4.04e-05	0.000432	CcSEcCtD
Epirubicin—Back pain—Docetaxel—melanoma	4.03e-05	0.000431	CcSEcCtD
Epirubicin—Muscle spasms—Docetaxel—melanoma	4e-05	0.000429	CcSEcCtD
Epirubicin—Hypersensitivity—Carmustine—melanoma	3.9e-05	0.000417	CcSEcCtD
Epirubicin—Diarrhoea—Dactinomycin—melanoma	3.87e-05	0.000414	CcSEcCtD
Epirubicin—Vomiting—Bleomycin—melanoma	3.85e-05	0.000412	CcSEcCtD
Epirubicin—Anaemia—Docetaxel—melanoma	3.85e-05	0.000412	CcSEcCtD
Epirubicin—Rash—Bleomycin—melanoma	3.82e-05	0.000409	CcSEcCtD
Epirubicin—Dermatitis—Bleomycin—melanoma	3.82e-05	0.000409	CcSEcCtD
Epirubicin—Asthenia—Carmustine—melanoma	3.79e-05	0.000406	CcSEcCtD
Epirubicin—Hypersensitivity—Temozolomide—melanoma	3.76e-05	0.000403	CcSEcCtD
Epirubicin—Syncope—Docetaxel—melanoma	3.73e-05	0.0004	CcSEcCtD
Epirubicin—Leukopenia—Docetaxel—melanoma	3.73e-05	0.000399	CcSEcCtD
Epirubicin—Palpitations—Docetaxel—melanoma	3.68e-05	0.000394	CcSEcCtD
Epirubicin—Asthenia—Temozolomide—melanoma	3.67e-05	0.000392	CcSEcCtD
Epirubicin—Loss of consciousness—Docetaxel—melanoma	3.66e-05	0.000392	CcSEcCtD
Epirubicin—Cough—Docetaxel—melanoma	3.63e-05	0.000389	CcSEcCtD
Epirubicin—Diarrhoea—Carmustine—melanoma	3.62e-05	0.000387	CcSEcCtD
Epirubicin—Pruritus—Temozolomide—melanoma	3.61e-05	0.000387	CcSEcCtD
Epirubicin—Convulsion—Docetaxel—melanoma	3.61e-05	0.000386	CcSEcCtD
Epirubicin—Nausea—Bleomycin—melanoma	3.6e-05	0.000385	CcSEcCtD
Epirubicin—Hypertension—Docetaxel—melanoma	3.59e-05	0.000385	CcSEcCtD
Epirubicin—Vomiting—Dactinomycin—melanoma	3.59e-05	0.000385	CcSEcCtD
Epirubicin—Rash—Dactinomycin—melanoma	3.56e-05	0.000381	CcSEcCtD
Epirubicin—Chest pain—Docetaxel—melanoma	3.54e-05	0.000379	CcSEcCtD
Epirubicin—Arthralgia—Docetaxel—melanoma	3.54e-05	0.000379	CcSEcCtD
Epirubicin—Myalgia—Docetaxel—melanoma	3.54e-05	0.000379	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	3.52e-05	0.000377	CcSEcCtD
Epirubicin—Dizziness—Carmustine—melanoma	3.5e-05	0.000374	CcSEcCtD
Epirubicin—Diarrhoea—Temozolomide—melanoma	3.5e-05	0.000374	CcSEcCtD
Epirubicin—Dry mouth—Docetaxel—melanoma	3.47e-05	0.000371	CcSEcCtD
Epirubicin—Confusional state—Docetaxel—melanoma	3.43e-05	0.000367	CcSEcCtD
Epirubicin—Anaphylactic shock—Docetaxel—melanoma	3.4e-05	0.000364	CcSEcCtD
Epirubicin—Oedema—Docetaxel—melanoma	3.4e-05	0.000364	CcSEcCtD
Epirubicin—Dizziness—Temozolomide—melanoma	3.38e-05	0.000362	CcSEcCtD
Epirubicin—Infection—Docetaxel—melanoma	3.38e-05	0.000361	CcSEcCtD
Epirubicin—Vomiting—Carmustine—melanoma	3.36e-05	0.00036	CcSEcCtD
Epirubicin—Nausea—Dactinomycin—melanoma	3.36e-05	0.000359	CcSEcCtD
Epirubicin—Shock—Docetaxel—melanoma	3.34e-05	0.000358	CcSEcCtD
Epirubicin—Rash—Carmustine—melanoma	3.33e-05	0.000357	CcSEcCtD
Epirubicin—Nervous system disorder—Docetaxel—melanoma	3.33e-05	0.000357	CcSEcCtD
Epirubicin—Dermatitis—Carmustine—melanoma	3.33e-05	0.000357	CcSEcCtD
Epirubicin—Thrombocytopenia—Docetaxel—melanoma	3.33e-05	0.000356	CcSEcCtD
Epirubicin—Tachycardia—Docetaxel—melanoma	3.32e-05	0.000355	CcSEcCtD
Epirubicin—Headache—Carmustine—melanoma	3.31e-05	0.000355	CcSEcCtD
Epirubicin—Skin disorder—Docetaxel—melanoma	3.3e-05	0.000353	CcSEcCtD
Epirubicin—Vomiting—Temozolomide—melanoma	3.25e-05	0.000348	CcSEcCtD
Epirubicin—Anorexia—Docetaxel—melanoma	3.24e-05	0.000347	CcSEcCtD
Epirubicin—Rash—Temozolomide—melanoma	3.22e-05	0.000345	CcSEcCtD
Epirubicin—Dermatitis—Temozolomide—melanoma	3.22e-05	0.000345	CcSEcCtD
Epirubicin—Headache—Temozolomide—melanoma	3.2e-05	0.000343	CcSEcCtD
Epirubicin—Hypotension—Docetaxel—melanoma	3.17e-05	0.00034	CcSEcCtD
Epirubicin—Nausea—Carmustine—melanoma	3.14e-05	0.000336	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Docetaxel—melanoma	3.1e-05	0.000331	CcSEcCtD
Epirubicin—Insomnia—Docetaxel—melanoma	3.07e-05	0.000329	CcSEcCtD
Epirubicin—Paraesthesia—Docetaxel—melanoma	3.05e-05	0.000327	CcSEcCtD
Epirubicin—Nausea—Temozolomide—melanoma	3.03e-05	0.000325	CcSEcCtD
Epirubicin—Dyspnoea—Docetaxel—melanoma	3.03e-05	0.000324	CcSEcCtD
Epirubicin—Somnolence—Docetaxel—melanoma	3.02e-05	0.000323	CcSEcCtD
Epirubicin—Dyspepsia—Docetaxel—melanoma	2.99e-05	0.00032	CcSEcCtD
Epirubicin—Decreased appetite—Docetaxel—melanoma	2.95e-05	0.000316	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Docetaxel—melanoma	2.93e-05	0.000314	CcSEcCtD
Epirubicin—Fatigue—Docetaxel—melanoma	2.93e-05	0.000314	CcSEcCtD
Epirubicin—Pain—Docetaxel—melanoma	2.91e-05	0.000311	CcSEcCtD
Epirubicin—Constipation—Docetaxel—melanoma	2.91e-05	0.000311	CcSEcCtD
Epirubicin—Feeling abnormal—Docetaxel—melanoma	2.8e-05	0.0003	CcSEcCtD
Epirubicin—Gastrointestinal pain—Docetaxel—melanoma	2.78e-05	0.000297	CcSEcCtD
Epirubicin—Abdominal pain—Docetaxel—melanoma	2.69e-05	0.000288	CcSEcCtD
Epirubicin—Body temperature increased—Docetaxel—melanoma	2.69e-05	0.000288	CcSEcCtD
Epirubicin—Hypersensitivity—Docetaxel—melanoma	2.5e-05	0.000268	CcSEcCtD
Epirubicin—Asthenia—Docetaxel—melanoma	2.44e-05	0.000261	CcSEcCtD
Epirubicin—Pruritus—Docetaxel—melanoma	2.4e-05	0.000257	CcSEcCtD
Epirubicin—Diarrhoea—Docetaxel—melanoma	2.32e-05	0.000249	CcSEcCtD
Epirubicin—Dizziness—Docetaxel—melanoma	2.25e-05	0.000241	CcSEcCtD
Epirubicin—Vomiting—Docetaxel—melanoma	2.16e-05	0.000231	CcSEcCtD
Epirubicin—Rash—Docetaxel—melanoma	2.14e-05	0.000229	CcSEcCtD
Epirubicin—Dermatitis—Docetaxel—melanoma	2.14e-05	0.000229	CcSEcCtD
Epirubicin—Headache—Docetaxel—melanoma	2.13e-05	0.000228	CcSEcCtD
Epirubicin—Nausea—Docetaxel—melanoma	2.02e-05	0.000216	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—ALB—melanoma	8.7e-06	0.000131	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MDM2—melanoma	8.6e-06	0.00013	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—melanoma	8.59e-06	0.000129	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLA2G6—melanoma	8.58e-06	0.000129	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MAPK1—melanoma	8.41e-06	0.000127	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	8.38e-06	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	8.34e-06	0.000126	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP17A1—melanoma	8.3e-06	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR2—melanoma	8.26e-06	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP17A1—melanoma	8.14e-06	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAC2—melanoma	8.13e-06	0.000122	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	8.11e-06	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.02e-06	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFC—melanoma	8e-06	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—WNT5A—melanoma	8e-06	0.000121	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTEN—melanoma	7.95e-06	0.00012	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—melanoma	7.92e-06	0.000119	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—melanoma	7.85e-06	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—melanoma	7.84e-06	0.000118	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNA11—melanoma	7.83e-06	0.000118	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—VCAN—melanoma	7.7e-06	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNA11—melanoma	7.68e-06	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CB—melanoma	7.68e-06	0.000116	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—FASN—melanoma	7.67e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CSF2—melanoma	7.66e-06	0.000115	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC5A5—melanoma	7.54e-06	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—FASN—melanoma	7.52e-06	0.000113	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—melanoma	7.49e-06	0.000113	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—melanoma	7.42e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC5A5—melanoma	7.4e-06	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCA—melanoma	7.35e-06	0.000111	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GAB2—melanoma	7.33e-06	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.29e-06	0.00011	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNAQ—melanoma	7.28e-06	0.00011	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CD44—melanoma	7.28e-06	0.00011	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—melanoma	7.25e-06	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAP2K2—melanoma	7.18e-06	0.000108	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FASN—melanoma	7.17e-06	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CD44—melanoma	7.14e-06	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAQ—melanoma	7.14e-06	0.000108	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—melanoma	7.06e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—melanoma	7.06e-06	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.04e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2R—melanoma	7.02e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.99e-06	0.000105	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1B1—melanoma	6.98e-06	0.000105	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.93e-06	0.000104	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	6.91e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HDAC2—melanoma	6.89e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FOXO4—melanoma	6.89e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CXCR4—melanoma	6.89e-06	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1B1—melanoma	6.85e-06	0.000103	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD44—melanoma	6.81e-06	0.000103	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RAC1—melanoma	6.81e-06	0.000103	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRB—melanoma	6.8e-06	0.000102	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	6.72e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTK2B—melanoma	6.6e-06	9.95e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	6.58e-06	9.9e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP17A1—melanoma	6.5e-06	9.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNA11—melanoma	6.42e-06	9.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GAB2—melanoma	6.42e-06	9.68e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.41e-06	9.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FLT1—melanoma	6.4e-06	9.63e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	6.33e-06	9.53e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT3—melanoma	6.29e-06	9.47e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK3—melanoma	6.18e-06	9.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNA11—melanoma	6.14e-06	9.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.04e-06	9.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FOXO4—melanoma	6.04e-06	9.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HDAC2—melanoma	6.04e-06	9.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR4—melanoma	6.04e-06	9.1e-05	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	6.02e-06	9.06e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—melanoma	6.01e-06	9.05e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—FASN—melanoma	6.01e-06	9.05e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—melanoma	6e-06	9.03e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNAQ—melanoma	5.97e-06	9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NRAS—melanoma	5.92e-06	8.92e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC5A5—melanoma	5.91e-06	8.9e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK1—melanoma	5.88e-06	8.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CG—melanoma	5.75e-06	8.67e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCB1—melanoma	5.75e-06	8.66e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNAQ—melanoma	5.71e-06	8.6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CD44—melanoma	5.71e-06	8.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK3—melanoma	5.67e-06	8.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCB1—melanoma	5.64e-06	8.49e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SYK—melanoma	5.62e-06	8.46e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—melanoma	5.61e-06	8.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.59e-06	8.42e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB4—melanoma	5.55e-06	8.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.54e-06	8.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT3—melanoma	5.51e-06	8.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NGFR—melanoma	5.51e-06	8.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ITGAV—melanoma	5.51e-06	8.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN2B—melanoma	5.51e-06	8.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1B1—melanoma	5.47e-06	8.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK1—melanoma	5.4e-06	8.13e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD86—melanoma	5.33e-06	8.02e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PRKCA—melanoma	5.29e-06	7.97e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ERCC2—melanoma	5.25e-06	7.91e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PRKCA—melanoma	5.19e-06	7.82e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF1—melanoma	5.16e-06	7.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ERCC2—melanoma	5.15e-06	7.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS1—melanoma	5.1e-06	7.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KRAS—melanoma	5.1e-06	7.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAP2K1—melanoma	5.09e-06	7.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—S100B—melanoma	5.09e-06	7.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CD—melanoma	5.06e-06	7.62e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PDGFRA—melanoma	5e-06	7.53e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCA—melanoma	4.95e-06	7.46e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—melanoma	4.94e-06	7.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERCC2—melanoma	4.91e-06	7.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB4—melanoma	4.87e-06	7.33e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAP2K2—melanoma	4.84e-06	7.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.83e-06	7.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN2B—melanoma	4.83e-06	7.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—melanoma	4.68e-06	7.05e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD86—melanoma	4.67e-06	7.03e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—melanoma	4.63e-06	6.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TERT—melanoma	4.6e-06	6.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HLA-A—melanoma	4.6e-06	6.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RAC1—melanoma	4.59e-06	6.91e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—melanoma	4.58e-06	6.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—melanoma	4.53e-06	6.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF1—melanoma	4.53e-06	6.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSF2—melanoma	4.53e-06	6.82e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—melanoma	4.51e-06	6.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—E2F1—melanoma	4.43e-06	6.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CB—melanoma	4.41e-06	6.64e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIF1A—melanoma	4.4e-06	6.63e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDGFRA—melanoma	4.38e-06	6.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ITGB3—melanoma	4.34e-06	6.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCA—melanoma	4.34e-06	6.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—melanoma	4.33e-06	6.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.26e-06	6.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—melanoma	4.26e-06	6.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAP2K2—melanoma	4.24e-06	6.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—melanoma	4.24e-06	6.38e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PRKCA—melanoma	4.15e-06	6.25e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CG—melanoma	4.14e-06	6.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ERCC2—melanoma	4.11e-06	6.19e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CG—melanoma	4.06e-06	6.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—melanoma	4.05e-06	6.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TERT—melanoma	4.03e-06	6.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAC1—melanoma	4.02e-06	6.06e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—melanoma	4e-06	6.03e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—melanoma	4e-06	6.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOTCH1—melanoma	3.97e-06	5.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—melanoma	3.92e-06	5.91e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD80—melanoma	3.89e-06	5.85e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KIT—melanoma	3.88e-06	5.84e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APC—melanoma	3.88e-06	5.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—melanoma	3.86e-06	5.81e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGF—melanoma	3.83e-06	5.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—melanoma	3.83e-06	5.76e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—melanoma	3.69e-06	5.56e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BRAF—melanoma	3.65e-06	5.49e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CD—melanoma	3.64e-06	5.49e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—melanoma	3.6e-06	5.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CD—melanoma	3.57e-06	5.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—melanoma	3.55e-06	5.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—melanoma	3.53e-06	5.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH1—melanoma	3.48e-06	5.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAP2K1—melanoma	3.43e-06	5.17e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CD—melanoma	3.41e-06	5.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.41e-06	5.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD80—melanoma	3.41e-06	5.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CG—melanoma	3.4e-06	5.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KIT—melanoma	3.4e-06	5.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APC—melanoma	3.4e-06	5.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—NRAS—melanoma	3.4e-06	5.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGF—melanoma	3.36e-06	5.06e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF2—melanoma	3.26e-06	4.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK3—melanoma	3.26e-06	4.9e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CG—melanoma	3.25e-06	4.89e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BRAF—melanoma	3.19e-06	4.81e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CB—melanoma	3.18e-06	4.78e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—melanoma	3.15e-06	4.74e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—melanoma	3.13e-06	4.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CB—melanoma	3.11e-06	4.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—melanoma	3.11e-06	4.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK1—melanoma	3.1e-06	4.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—melanoma	3.1e-06	4.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—melanoma	3.09e-06	4.65e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MDM2—melanoma	3.05e-06	4.6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB2—melanoma	3.01e-06	4.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAP2K1—melanoma	3.01e-06	4.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CD—melanoma	2.99e-06	4.5e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CB—melanoma	2.97e-06	4.48e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—melanoma	2.97e-06	4.47e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—melanoma	2.94e-06	4.44e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—melanoma	2.93e-06	4.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF2—melanoma	2.86e-06	4.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CD—melanoma	2.86e-06	4.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—melanoma	2.82e-06	4.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—melanoma	2.79e-06	4.2e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—melanoma	2.74e-06	4.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—melanoma	2.69e-06	4.05e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—melanoma	2.69e-06	4.05e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MDM2—melanoma	2.68e-06	4.03e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—melanoma	2.64e-06	3.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—melanoma	2.63e-06	3.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CB—melanoma	2.6e-06	3.92e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—melanoma	2.57e-06	3.88e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—melanoma	2.57e-06	3.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—melanoma	2.5e-06	3.77e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CB—melanoma	2.49e-06	3.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—melanoma	2.49e-06	3.75e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—melanoma	2.47e-06	3.71e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—melanoma	2.44e-06	3.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—melanoma	2.4e-06	3.61e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—melanoma	2.39e-06	3.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—melanoma	2.38e-06	3.58e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—melanoma	2.33e-06	3.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—melanoma	2.31e-06	3.48e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—melanoma	2.3e-06	3.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NRAS—melanoma	2.29e-06	3.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—melanoma	2.26e-06	3.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—melanoma	2.26e-06	3.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—melanoma	2.25e-06	3.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKB1—melanoma	2.24e-06	3.37e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—melanoma	2.2e-06	3.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK3—melanoma	2.19e-06	3.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—melanoma	2.15e-06	3.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—melanoma	2.13e-06	3.21e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK1—melanoma	2.09e-06	3.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—melanoma	2.09e-06	3.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—melanoma	2.03e-06	3.06e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—melanoma	2.01e-06	3.03e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NRAS—melanoma	2.01e-06	3.02e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—melanoma	1.97e-06	2.97e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—melanoma	1.94e-06	2.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK3—melanoma	1.92e-06	2.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—melanoma	1.9e-06	2.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—melanoma	1.87e-06	2.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK1—melanoma	1.83e-06	2.76e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—melanoma	1.83e-06	2.76e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—melanoma	1.81e-06	2.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—melanoma	1.73e-06	2.6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—melanoma	1.68e-06	2.52e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—melanoma	1.6e-06	2.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—melanoma	1.59e-06	2.39e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—melanoma	1.58e-06	2.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—melanoma	1.55e-06	2.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—melanoma	1.54e-06	2.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—melanoma	1.52e-06	2.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—melanoma	1.48e-06	2.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—melanoma	1.47e-06	2.21e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—melanoma	1.41e-06	2.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—melanoma	1.3e-06	1.95e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—melanoma	1.24e-06	1.87e-05	CbGpPWpGaD
